Itoh Y, Sugimoto T, Ukai Y, Morino A, Kimura K
Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Japan.
J Pharm Pharmacol. 1995 Oct;47(10):833-6. doi: 10.1111/j.2042-7158.1995.tb05750.x.
The concentration of NS-3 (montirelin hydrate, CG 3703), a thyrotropin-releasing hormone (TRH) analogue, in the cerebral cortex of urethane-anaesthetized rats was measured after its systemic administration (1 mg kg-1, i.v.), using in-vivo microdialysis coupled with a radioimmunoassay. The concentration in microdialysates was highest (24 nM) during the first 20 min after injection, and it fell below the detection limit (3.5 nM) 100 min after treatment. The maximal interstitial concentration was estimated to be 0.51 microM. From these results, it is suggested that NS-3 can readily penetrate into the brain.
在对氨基甲酸乙酯麻醉的大鼠进行全身给药(静脉注射1 mg/kg)后,采用体内微透析结合放射免疫分析法,测定了促甲状腺激素释放激素(TRH)类似物NS-3(蒙特瑞林水合物,CG 3703)在大鼠大脑皮层中的浓度。注射后最初20分钟内,微透析液中的浓度最高(24 nM),给药100分钟后降至检测限(3.5 nM)以下。最大间质浓度估计为0.51 microM。根据这些结果,提示NS-3能够轻易穿透血脑屏障进入大脑。